申请人:Incyte Corporation
公开号:US20170158670A1
公开(公告)日:2017-06-08
The present disclosure describes pyridineamine compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the Pim kinases, and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.